Patient Consent Form - Treatment (District of Columbia)
note and tailor language for the specific Treatment.
3. Remove guidance comments before final execution.
4. Have a D.C.-licensed attorney and the treating clinician review before use.
JURISDICTION: District of Columbia
LAST UPDATED: 2026-05-10
-->
DISCLAIMER (MANDATORY – DO NOT DELETE)
The following document is a model template for educational purposes only and does not constitute legal or medical advice. Use of this template does not create an attorney-client or physician-patient relationship. District of Columbia and federal requirements governing informed consent, mental-health treatment, minor consent, and medical malpractice are complex and frequently updated; a qualified District of Columbia-licensed attorney and the treating clinician must review, customize, and approve this form before implementation.
PATIENT CONSENT TO TREATMENT
(District of Columbia – Comprehensive Informed Consent Form)
| Field | Value |
|---|---|
| Effective Date | [__/__/____] |
| Provider Entity | [LEGAL NAME OF HOSPITAL / CLINIC / PHYSICIAN GROUP] ("Provider") |
| Treating Clinician | [NAME, D.C. LICENSE NO., NPI NO.] |
| Patient | [LEGAL NAME, DOB] ("Patient") |
| Authorized Representative (if any) | [NAME & RELATIONSHIP] ("Representative") |
| Governing Law | District of Columbia |
I. PURPOSE AND ACKNOWLEDGMENT
A. Purpose. This Agreement records the informed consent of Patient (or Representative) for one or more medical treatments, procedures, examinations, or services (collectively, "Treatment") furnished by Provider, in conformity with the District of Columbia "reasonable patient" / "material-risk" disclosure standard articulated in Crain v. Allison, 443 A.2d 558 (D.C. 1982).
B. Consideration. In consideration of Provider's agreement to render Treatment and related services, the Parties agree as set forth below.
C. Receipt. Patient acknowledges receipt of a copy of this Agreement and confirms its provisions were explained in plain, understandable language, with reasonable opportunity to ask questions.
II. DEFINITIONS
"Adverse Event" – Any unanticipated injury or complication arising from Treatment that may require further medical intervention.
"Capacity" – The ability to understand the nature, purpose, material risks, expected benefits, and reasonable alternatives of Treatment, and to communicate a decision, evaluated consistent with D.C. Code § 21-2202 and § 21-2204.
"Confidential Information / PHI" – Individually identifiable health information protected under HIPAA (45 C.F.R. Parts 160, 164) and District of Columbia confidentiality law.
"Emergency Condition" – A condition in which delay would jeopardize Patient's life, health, or bodily function and informed consent cannot practicably be obtained; under such circumstances consent is implied at common law.
"Informed Consent" – Voluntary authorization given after disclosure of (i) diagnosis; (ii) nature and purpose of the proposed Treatment; (iii) material risks a reasonable patient would consider significant; (iv) expected benefits; (v) reasonable alternatives, including no Treatment; and (vi) answers to Patient's questions, as required by Crain v. Allison.
"Substituted Consent" – Consent obtained from an authorized surrogate in the priority order set forth in D.C. Code § 21-2210 when Patient lacks Capacity and has no operative advance directive.
"Parties" – Provider, Patient, and Representative (if any), collectively.
III. DISCLOSURE OF TREATMENT (Material-Risk Standard)
3.1 Description of Proposed Treatment. [DETAILED CLINICAL DESCRIPTION].
3.2 Expected Benefits. [LIST].
3.3 Material Risks and Complications. Provider has disclosed risks a reasonable patient in Patient's circumstances would consider material to the decision, including, without limitation: [LIST – or attach Schedule 1].
3.4 Reasonable Alternatives (including no Treatment) and their respective risks and benefits: [LIST].
3.5 Consequences of Declining or Delaying Treatment. [LIST].
3.6 Provider Identity / Multi-Provider Care. Patient understands that residents, fellows, students, advanced-practice clinicians, anesthesiologists, pathologists, radiologists, or other personnel may participate in Treatment under appropriate supervision.
3.7 Photography / Recording. Patient ☐ consents / ☐ does not consent to clinical photography, audio, or video recording for medical-record, educational, or quality-improvement purposes.
3.8 Tissue / Specimen Disposition. Patient ☐ consents / ☐ does not consent to retention and clinically appropriate disposal of tissue, fluids, or specimens removed during Treatment.
3.9 Blood and Blood Products. Patient ☐ consents / ☐ refuses transfusion of blood or blood products, understanding the risks of refusal.
IV. CAPACITY, SURROGATE, AND MINOR CONSENT
4.1 Adult Capacity Verification. Provider has assessed Patient's Capacity. ☐ Patient has Capacity and signs personally. ☐ Patient lacks Capacity; Substituted Consent obtained per § 4.2.
4.2 Substituted Consent (D.C. Code § 21-2210). Where Patient lacks Capacity and has no agent under a durable power of attorney for health care, Substituted Consent is obtained in the statutory priority order: (a) court-appointed guardian; (b) spouse or domestic partner; (c) adult child; (d) parent; (e) adult sibling; (f) religious superior (clergy); (g) close friend; (h) nearest living relative.
4.3 Advance Directive. ☐ Patient has executed a Durable Power of Attorney for Health Care, Living Will, or MOLST/POLST, copy attached. ☐ None on file.
4.4 Minor Patients.
- ☐ Parent / legal guardian consents on behalf of an unemancipated minor.
- ☐ Emancipated minor signs personally (D.C. Code § 16-4901 et seq.).
- ☐ Self-consent for sensitive services as permitted by D.C. law:
- STD diagnosis / treatment by a minor of any age (D.C. Code § 22-3014).
- Outpatient mental health services or supports for a voluntarily-seeking minor (D.C. Code § 7-1231.14), limited to ninety (90) days absent parental consent; psychotropic medication self-consent permitted only for minors aged 16 or older under the conditions of § 7-1231.14.
- Other sensitive services per applicable D.C. authority.
4.5 Mental-Health Capacity. Where Treatment implicates mental-health services, Provider documents Capacity and consent consistent with the Mental Health Information Act and D.C. Code § 21-2204.
V. EMERGENCY EXCEPTION
5.1 Implied Consent in Emergency. In an Emergency Condition where Patient lacks Capacity and no surrogate is reasonably available, Provider may render Treatment reasonably necessary to preserve life or prevent serious impairment, under the District of Columbia common-law emergency-consent doctrine. Provider shall document the nature of the emergency, the unavailability of consent, and the Treatment rendered.
VI. PRIVACY, RECORDS, AND COMMUNICATIONS
6.1 HIPAA / D.C. Confidentiality. Provider will use and disclose PHI only for treatment, payment, and health-care operations, except as authorized by Patient or required by law.
6.2 Notice of Privacy Practices. Patient acknowledges receipt of Provider's current Notice of Privacy Practices (Schedule 2).
6.3 Communications. Patient authorizes contact at: ☐ phone [____] ☐ email [____] ☐ patient portal ☐ U.S. mail. Patient may revoke or modify communication preferences in writing.
6.4 Recordkeeping. Provider maintains records consistent with D.C. Code Title 3 (Health Occupations Revision Act) and HIPAA.
VII. FINANCIAL RESPONSIBILITY
7.1 Patient is responsible for charges associated with Treatment that are not covered by insurance or other third-party payor, subject to Provider's billing and financial-assistance policies. [INSERT BILLING / GOOD-FAITH-ESTIMATE LANGUAGE].
7.2 Patient acknowledges receipt of any required Good Faith Estimate under the federal No Surprises Act (where applicable).
VIII. VOLUNTARINESS, QUESTIONS, AND WITHDRAWAL
8.1 Voluntary. Consent is given freely; Patient was not coerced.
8.2 Questions Answered. Provider answered Patient's questions to Patient's satisfaction.
8.3 Right to Withdraw. Patient may withdraw consent in writing at any time before Treatment is rendered (and during Treatment to the extent medically safe), without penalty other than financial responsibility for services already rendered.
IX. REPRESENTATIONS AND WARRANTIES
9.1 Patient / Representative. (a) Authority – Representative warrants legal authority under § 21-2210 or applicable instrument; (b) Accuracy – the medical, insurance, and identity information furnished is true and complete; (c) Understanding – Patient/Representative understands this Agreement.
9.2 Provider. (a) Licensure under the D.C. Health Occupations Revision Act, D.C. Code § 3-1201 et seq.; (b) Treatment consistent with the prevailing professional standard of care; (c) Disclosures sufficient under Crain v. Allison.
X. DISPUTE RESOLUTION
10.1 Governing Law. District of Columbia law governs, without regard to conflict-of-laws principles.
10.2 Forum. Exclusive venue lies in the Superior Court of the District of Columbia, except as preempted by federal law.
10.3 Jury Trial. The Parties acknowledge the constitutional right to jury trial and do not waive that right herein.
10.4 No Limitation of Malpractice Claims. Nothing in this Agreement limits Provider's liability for professional negligence or constitutes a waiver of any cause of action arising from a deviation from the standard of care.
XI. GENERAL PROVISIONS
11.1 Amendments. Must be in a writing signed by both Parties.
11.2 Severability. If any provision is held unenforceable, the remainder remains in effect.
11.3 Integration. This Agreement, together with attached Schedules and Provider's Notice of Privacy Practices, is the entire agreement on its subject matter.
11.4 Counterparts; Electronic Signatures. Permitted; each counterpart is deemed an original.
XII. EXECUTION
IN WITNESS WHEREOF, the Parties execute this Agreement as of the Effective Date.
A. Patient / Representative
| Signature | Printed Name | Date | Capacity (Patient / Representative) | Relationship |
|---|---|---|---|---|
| [SIGN] | [PRINT] | [__/__/____] | [SELECT] | [IF APPLICABLE] |
B. Treating Clinician / Provider
| Signature | Printed Name & Title | Date | D.C. License / NPI No. |
|---|---|---|---|
| [SIGN] | [PRINT] | [__/__/____] | [INSERT] |
C. Witness (if required by facility policy or for surrogate consent)
| Signature | Printed Name | Date |
|---|---|---|
| [SIGN] | [PRINT] | [__/__/____] |
SCHEDULE 1 – PROCEDURE-SPECIFIC MATERIAL RISKS AND ALTERNATIVES
SCHEDULE 2 – NOTICE OF PRIVACY PRACTICES
SOURCES AND REFERENCES
- Crain v. Allison, 443 A.2d 558 (D.C. 1982).
- D.C. Code § 21-2201 et seq. (Health-Care Decisions Act).
- D.C. Code § 21-2210 (Substituted Consent priority list).
- D.C. Code § 7-1231.14 (Minor consent to mental-health services).
- D.C. Code § 22-3014 (Minor consent for STD).
- D.C. Code § 16-4901 et seq. (Emancipation).
- D.C. Code § 3-1201 et seq. (Health Occupations Revision Act).
- 45 C.F.R. Parts 160, 164 (HIPAA).
About This Template
These templates cover the everyday paperwork that happens between patients, providers, and health plans: consent forms, medical record authorizations, directives for end-of-life care, and requests to approve or deny treatment. Getting them right matters because they document medical decisions, release sensitive health information, and often have to meet both federal privacy rules and state-specific requirements. A form that is missing a required disclosure can be rejected by a provider or challenged later in court.
Important Notice
This template is provided for informational purposes. It is not legal advice. We recommend having an attorney review any legal document before signing, especially for high-value or complex matters.
Last updated: May 2026